Enhanced Sensitivity of Insulin-resistant Adipocytes to Vanadate Is Associated with Oxidative Stress and Decreased Reduction of Vanadate (+5) to Vanadyl (+4)*

Vanadate (sodium orthovanadate), an inhibitor of phosphotyrosine phosphatases (PTPs), mimics many of the metabolic actions of insulin in vitro and in vivo. The potential of vanadate to stimulate glucose transport independent of the early steps in insulin signaling prompted us to test its effectiveness in an in vitro model of insulin resistance. In primary rat adipocytes cultured for 18 h in the presence of high glucose (15 mm) and insulin (10−7 m), sensitivity to insulin-stimulated glucose transport was decreased. In contrast, there was a paradoxical enhanced sensitivity to vanadate of the insulin-resistant cells (EC50 for control, 325 ± 7.5 μm; EC50 for insulin-resistant, 171 ± 32 μm; p < 0.002). Enhanced sensitivity was also present for vanadate stimulation of insulin receptor kinase activity and autophosphorylation and Akt/protein kinase B Ser-473 phosphorylation consistent with more effective PTP inhibition in the resistant cells. Investigation of this phenomenon revealed that 1) depletion of GSH with buthionine sulfoximine reproduced the enhanced sensitivity to vanadate while preincubation of resistant cells withN-acetylcysteine (NAC) prevented it, 2) intracellular GSH was decreased in resistant cells and normalized by NAC, 3) exposure to high glucose and insulin induced an increase in reactive oxygen species, which was prevented by NAC, 4) EPR (electron paramagnetic resonance) spectroscopy showed a decreased amount of vanadyl (+4) in resistant and buthionine sulfoximine-treated cells, which correlated with decreased GSH and increased vanadate sensitivity, while total vanadium uptake was not altered, and 5) inhibition of recombinant PTP1Bin vitro was more sensitive to vanadate (+5) than vanadyl (+4). In conclusion, the parodoxical increased sensitivity to vanadate in hyperglycemia-induced insulin resistant adipocytes is due to oxidative stress and decreased reduction of vanadate (+5) to vanadyl (+4). Thus, sensitivity of PTP inhibition and glucose transport to vanadate is regulated by cellular redox state.

[1]  L. Casella,et al.  The intensity of vanadium(V)-induced cytotoxicity and morphological transformation in BALB/3T3 cells is dependent on glutathione-mediated bioreduction to vanadium(IV). , 1993, Carcinogenesis.

[2]  J. Woodgett,et al.  Protein Kinase B/Akt Participates in GLUT4 Translocation by Insulin in L6 Myoblasts , 1999, Molecular and Cellular Biology.

[3]  G. Elberg,et al.  Evidence for the distinct vanadyl(+4)-dependent activating system for manifesting insulin-like effects. , 1996, Biochemistry.

[4]  J. McNeill,et al.  Effect of vanadate on elevated blood glucose and depressed cardiac performance of diabetic rats. , 1985, Science.

[5]  R. Bartrons,et al.  Insulin-like effects of vanadate on glucokinase activity and fructose 2,6-bisphosphate levels in the liver of diabetic rats. , 1988, The Journal of biological chemistry.

[6]  Ferhaan Ahmad,et al.  Vanadate augments insulin binding and prolongs insulin action in rat adipocytes. , 1990, Endocrinology.

[7]  I. G. Fantus,et al.  Peroxovanadium compounds. A new class of potent phosphotyrosine phosphatase inhibitors which are insulin mimetics. , 1994, The Journal of biological chemistry.

[8]  M. Kasuga,et al.  From receptor to transporter: insulin signalling to glucose transport , 1997, Diabetologia.

[9]  A. Ullrich,et al.  Tumor necrosis factor-alpha- and hyperglycemia-induced insulin resistance. Evidence for different mechanisms and different effects on insulin signaling. , 1996, The Journal of clinical investigation.

[10]  J. Olefsky.  Mechanisms of the ability of insulin to activate the glucose-transport system in rat adipocytes. , 1978, The Biochemical journal.

[11]  B. Kahn.  Type 2 Diabetes: When Insulin Secretion Fails to Compensate for Insulin Resistance , 1998, Cell.

[12]  Jerrold M. Olefsky,et al.  Protein-tyrosine Phosphatase 1B Is a Negative Regulator of Insulin- and Insulin-like Growth Factor-I-stimulated Signaling* , 1996, The Journal of Biological Chemistry.

[13]  I. G. Fantus,et al.  Stimulation of insulin-like growth factor II receptor binding and insulin receptor kinase activity in rat adipocytes. Effects of vanadate and H2O2. , 1987, The Journal of biological chemistry.

[14]  M. Poznansky,et al.  The Insulin-Mimetic Agent Vanadate Promotes Receptor Endocytosis and Inhibits Intracellular Ligand-Receptor Degradation by a Mechanism Distinct From the Lysosomotropic Agents , 1996, Diabetes.

[15]  M. Birnbaum,et al.  Expression of a Constitutively Active Akt Ser/Thr Kinase in 3T3-L1 Adipocytes Stimulates Glucose Uptake and Glucose Transporter 4 Translocation* , 1996, The Journal of Biological Chemistry.

[16]  Robert V Farese,et al.  Activation of Protein Kinase C (α, β, and ζ) by Insulin in 3T3/L1 Cells , 1997, The Journal of Biological Chemistry.

[17]  I. G. Fantus,et al.  Pervanadate [peroxide(s) of vanadate] mimics insulin action in rat adipocytes via activation of the insulin receptor tyrosine kinase. , 1989, Biochemistry.

[18]  B. Kahn,et al.  Glucose transporters and insulin action--implications for insulin resistance and diabetes mellitus. , 1999, The New England journal of medicine.

[19]  Suppression of the hepatic glucose-6-phosphatase system in diabetic rats by vanadate. , 1988, Annals of nutrition & metabolism.

[20]  R. Henry,et al.  Skeletal muscle protein tyrosine phosphatase activity and tyrosine phosphatase 1B protein content are associated with insulin action and resistance. , 1994, The Journal of clinical investigation.

[21]  S. Watson,et al.  Activation of human platelets by peroxovanadate is associated with tyrosine phosphorylation of phospholipase C gamma and formation of inositol phosphates. , 1993, The Biochemical journal.

[22]  S. Brichard,et al.  Long term improvement of glucose homeostasis by vanadate treatment in diabetic rats. , 1988, Endocrinology.

[23]  S. Hashimoto,et al.  Pervanadate stimulation of wortmannin-sensitive and -resistant 2-deoxyglucose transport in adipocytes. , 1996, Biochemical pharmacology.

[24]  Y. Shechter.  Insulin-Mimetic Effects of Vanadate: Possible Implications for Future Treatment of Diabetes , 1990, Diabetes.

[25]  A. V. Xavier.  Frontiers in Bioinorganic chemistry , 1986 .

[26]  J. A. Scarlett,et al.  Role of Glucose Transport in the Postreceptor Defect of Non-insulin-dependent Diabetes Mellitus , 1982, Diabetes.

[27]  A. Tracey,et al.  Vanadate inhibition of protein tyrosine phosphatases in Jurkat cells: modulation by redox state , 1999, JBIC Journal of Biological Inorganic Chemistry.

[28]  P. Cerutti,et al.  High Glucose Induces Antioxidant Enzymes in Human Endothelial Cells in Culture: Evidence Linking Hyperglycemia and Oxidative Stress , 1996, Diabetes.

[29]  Simeon I. Taylor,et al.  Deconstructing Type 2 Diabetes , 1999, Cell.

[30]  M. Gresser,et al.  Mechanism of Inhibition of Protein-tyrosine Phosphatases by Vanadate and Pervanadate* , 1997, The Journal of Biological Chemistry.

[31]  G. Schieven,et al.  Role of Oxidative Stress in the Action of Vanadium Phosphotyrosine Phosphatase Inhibitors , 1997, The Journal of Biological Chemistry.

[32]  L. Cantley,et al.  Glutathione reduces cytoplasmic vanadate. Mechanism and physiological implications. , 1980, Biochimica et biophysica acta.

[33]  J. Olefsky,et al.  Insulin resistance and non-insulin-dependent diabetes mellitus: cellular and molecular mechanisms. , 1995, The American journal of clinical nutrition.

[34]  G. Elberg,et al.  Vanadate Activates Membranous Nonreceptor Protein Tyrosine Kinase in Rat Adipocytes , 1997, Diabetes.

[35]  P. Vicario,et al.  The insulin-mimetic effect of vanadate is not correlated with insulin receptor tyrosine kinase activity nor phosphorylation in mouse diaphragm in vivo. , 1989, Endocrinology.

[36]  Y. Shechter,et al.  Insulin-like stimulation of glucose oxidation in rat adipocytes by vanadyl (IV) ions , 1980, Nature.

[37]  I. G. Fantus,et al.  Tyrosine phosphatase inhibitors, vanadate and pervanadate, stimulate glucose transport and GLUT translocation in muscle cells by a mechanism independent of phosphatidylinositol 3-kinase and protein kinase C. , 1998, Diabetes.

[38]  H. Ischiropoulos,et al.  Evaluation of 2',7'-dichlorofluorescin and dihydrorhodamine 123 as fluorescent probes for intracellular H2O2 in cultured endothelial cells. , 1993, Archives of biochemistry and biophysics.

[39]  C. Kahn,et al.  Vanadate normalizes hyperglycemia in two mouse models of non-insulin-dependent diabetes mellitus. , 1991, The Journal of clinical investigation.

[40]  J. Olefsky,et al.  Glucose and insulin co-regulate the glucose transport system in primary cultured adipocytes. A new mechanism of insulin resistance. , 1987, The Journal of biological chemistry.

[41]  Philip R. Cohen,et al.  Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1. , 1998, Science.

[42]  A. Perl,et al.  Glutathione Levels and Sensitivity to Apoptosis Are Regulated by Changes in Transaldolase Expression* , 1996, The Journal of Biological Chemistry.

[43]  P. Cohen,et al.  Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Bα , 1997, Current Biology.

[44]  O. Aruoma,et al.  The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. , 1989, Free radical biology & medicine.

[45]  F. McCormick,et al.  Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B. , 1998, Science.

[46]  Ferhaan Ahmad,et al.  Vanadate Augments Insulin-Stimulated Insulin Receptor Kinase Activity and Prolongs Insulin Action In Rat Adipocytes: Evidence for Transduction of Amplitude of Signaling into Duration of Response , 1994, Diabetes.

[47]  M. White,et al.  IRS-1 activates phosphatidylinositol 3'-kinase by associating with src homology 2 domains of p85. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[48]  G. Reaven,et al.  In vitro insulin resistance of human adipocytes isolated from subjects with noninsulin-dependent diabetes mellitus. , 1983, The Journal of clinical investigation.

[49]  C. R. Kahn,et al.  Insulin Action, Diabetogenes, and the Cause of Type II Diabetes , 1994, Diabetes.

[50]  A. Green.  The insulin-like effect of sodium vanadate on adipocyte glucose transport is mediated at a post-insulin-receptor level. , 1986, The Biochemical journal.

[51]  H. Degani,et al.  Electron paramagnetic resonance studies and insulin-like effects of vanadium in rat adipocytes. , 1981, Biochemistry.

[52]  A. Srivastava,et al.  Activation of mitogen activated protein (MAP) kinases by vanadate is independent of insulin receptor autophosphorylation , 1994, FEBS letters.

[53]  J. K. Grady,et al.  Characterization of the binding, kinetics, and redox stability of vanadium(IV) and vanadium(V) protein complexes in serum , 1986 .

[54]  G. Elberg,et al.  Vanadium activates or inhibits receptor and non-receptor protein tyrosine kinases in cell-free experiments, depending on its oxidation state. Possible role of endogenous vanadium in controlling cellular protein tyrosine kinase activity. , 1994, The Journal of biological chemistry.

[55]  M. White,et al.  The insulin signalling system and the IRS proteins , 1997, Diabetologia.

[56]  I. G. Fantus,et al.  Decreased in situ insulin receptor dephosphorylation in hyperglycemia-induced insulin resistance in rat adipocytes. , 2001, Diabetes.

[57]  S. Brichard,et al.  The role of vanadium in the management of diabetes. , 1995, Trends in pharmacological sciences.

[58]  J. Olefsky,et al.  Protein Tyrosine Phosphatase 1B Interacts With the Activated Insulin Receptor , 1996, Diabetes.

[59]  S. Wolff,et al.  Protein glycation and oxidative stress in diabetes mellitus and ageing. , 1991, Free radical biology & medicine.

[60]  H. Shamoon,et al.  Oral Vanadyl Sulfate Improves Insulin Sensitivity in NIDDM but Not in Obese Nondiabetic Subjects , 1996, Diabetes.

[61]  L. Groop,et al.  Metabolic and genetic characterization of prediabetic states. Sequence of events leading to non-insulin-dependent diabetes mellitus. , 1994, The Journal of clinical investigation.

[62]  J. Dixon,et al.  Visualization of intermediate and transition-state structures in protein-tyrosine phosphatase catalysis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[63]  C. Hiort,et al.  Cleavage of DNA by the insulin-mimetic compound, NH4[VO(O2)2(phen)]. , 1996, Biochemistry.

[64]  G. Swarup,et al.  Phosphotyrosyl-protein phosphatase of TCRC-2 cells. , 1982, The Journal of biological chemistry.

[65]  S. Marshall,et al.  Role of amino acids in modulating glucose-induced desensitization of the glucose transport system. , 1989, The Journal of biological chemistry.

[66]  H. Shamoon,et al.  Oral vanadyl sulfate improves hepatic and peripheral insulin sensitivity in patients with non-insulin-dependent diabetes mellitus. , 1995, The Journal of clinical investigation.

[67]  P. Moldéus,et al.  [48] N-acetylcysteine , 1994 .

[68]  A. Kashiwagi,et al.  Impaired Activation of Glucose Oxidation and NADPH Supply in Human Endothelial Cells Exposed to H2O2 in High-Glucose Medium , 1995, Diabetes.

[69]  S. Nagataki,et al.  Significance of Glutathione Depletion and Oxidative Stress in Early Embryogenesis in Glucose-Induced Rat Embryo Culture , 1995, Diabetes.

[70]  B. Kennedy,et al.  Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. , 1999, Science.

[71]  T. Atkinson,et al.  Orthovanadate induces translocation of phospholipase C-gamma 1 and -gamma 2 in permeabilized mast cells. , 1993, Journal of immunology.

[72]  I. G. Fantus,et al.  Vanadium Compounds Biological Actions and Potential as Pharmacological Agents , 1997, Trends in Endocrinology & Metabolism.

[73]  S. Tamura,et al.  A novel mechanism for the insulin-like effect of vanadate on glycogen synthase in rat adipocytes. , 1984, The Journal of biological chemistry.

[74]  C. Kahn,et al.  Insulin action and the insulin signaling network. , 1995, Endocrine reviews.

[75]  A. Shisheva,et al.  Role of cytosolic tyrosine kinase in mediating insulin-like actions of vanadate in rat adipocytes. , 1993, The Journal of biological chemistry.

[76]  J. Pessin,et al.  Molecular Basis of Insulin-stimulated GLUT4 Vesicle Trafficking , 1999, The Journal of Biological Chemistry.

[77]  Lewis C. Cantley,et al.  The Role of Phosphoinositide 3-Kinase Lipid Products in Cell Function* , 1999, The Journal of Biological Chemistry.

[78]  A. Pansini,et al.  Effects of vanadium on glucose metabolism in vitro. , 1979, Life sciences.